Roche Holding AG
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2017-08-21
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 107
- Registration Number
- NCT01063062
- Locations
- 🇪🇬
Banha Educational Hospital; Rheumatology, Banha, Egypt
🇪🇬Kasr El Ainy Hospital; Rheumatology, Cairo, Egypt
🇪🇬Manial Specialized Hospital; Rheumatology, Cairo, Egypt
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
- First Posted Date
- 2010-02-01
- Last Posted Date
- 2020-03-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 936
- Registration Number
- NCT01059682
A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4
Phase 2
Completed
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2010-01-27
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 168
- Registration Number
- NCT01057667
A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe)
Phase 4
Completed
- Conditions
- Lymphocytic Leukemia, Chronic
- Interventions
- First Posted Date
- 2010-01-26
- Last Posted Date
- 2015-06-25
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 357
- Registration Number
- NCT01056510
A Study of Intravenous Oseltamivir [Tamiflu] in Infants With Influenza
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 9
- Registration Number
- NCT01053663
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
Completed
- Conditions
- Anemia
- Interventions
- Drug: methoxy polyethylene glycol-ep [Mircera]
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1580
- Registration Number
- NCT01051323
Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators
Not Applicable
Completed
- Conditions
- Diabetes Mellitus Type 1
- Interventions
- Device: Accu-Chek Combo Kit mg DE/de
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2016-03-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01050868
A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy
Phase 3
Terminated
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- First Posted Date
- 2010-01-18
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 370
- Registration Number
- NCT01051011
A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2013-11-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 118
- Registration Number
- NCT01050257
A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2016-09-14
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 62
- Registration Number
- NCT01046266
© Copyright 2025. All Rights Reserved by MedPath